Arvinas Inc. (NASDAQ:ARVN) is one of the best small cap stocks with biggest upside potential. On August 8, Arvinas, in ...

Pfizer Inc.’s stock was rallying Tuesday after the drug giant lifted its 2025 adjusted profit estimate, on the heels of a 10% ...

Pfizer's (NYSE:PFE) stock is up by a considerable 10% over the past three months. We wonder if and what role the company's financials play in that price change as a company's long-term fundamentals ...

Pfizer Inc. (NYSE:PFE) discovers, develops, markets, and sells biopharmaceutical products in the U.S. and internationally. It ...

Pfizer Inc. today announced the decision to discontinue development of danuglipron, an oral glucagon-like peptide-1 receptor agonist, which was being investigated for chronic weight management ...

Pfizer (PFE) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of ...

Shares of Pfizer Inc. PFE advanced 2.22% to $22.53 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 2.51% to 5,287.76 and ...

Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. is conducting a Phase 3 clinical study titled AN OPEN-LABEL, ...

Pfizer (NYSE:PFE) is set to announce its earnings on Tuesday, April 29, 2025. Reviewing PFE’s five-year history, the stock has experienced a balanced 50-50 distribution of positive and negative ...

S&P 500 component Pfizer Inc. reported its results for the fourth quarter. Pfizer is a global pharmaceutical company which develops and manufactures prescription medications for humans and animals.